[1]
“Botulinum Toxin Treatment Practice Recommendations for Movement Disorders Clinics During the COVID-19 Pandemic”, Acta Med Philipp, vol. 56, no. 5, Mar. 2022, doi: 10.47895/amp.vi0.2737.